Heart Disease News and Research

Latest Heart Disease News and Research

Mount Sinai researchers uncover genetic basis of fibromuscular dysplasia

Mount Sinai researchers have identified a key driver of a blood vessel disorder known as fibromuscular dysplasia (FMD) which affects up to five percent of the adult population and can lead to high blood pressure, heart attack, or stroke.

14 Sep 2024

Semaglutide and tirzepatide significantly improve weight loss and glycemic control in type 1 diabetes

Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with type 1 diabetes (T1D) who are living with overweight or obesity, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September) has found.

13 Sep 2024

Coordinated health teams may help improve outcomes for children with Trisomy 21 and heart conditions

A coordinated, multidisciplinary health care team to address the specific physical, psychological and developmental needs of children with Trisomy 21, or Down syndrome, and congenital heart disease may help children with these conditions lead longer and more productive lives, according to a new scientific statement from the American Heart Association.

13 Sep 2024

Advanced insulin pump technology improves diabetes management for marathon runners

A series of case reports to be presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept), describe how a technology giving insulin doses informed by an insulin pump algorithm helped three adults with type 1 diabetes better manage their blood sugars enabling them to lead more active lives, and even run marathons.

13 Sep 2024

Obesity medication liraglutide is safe and effective in children aged 6 to <12 years

Liraglutide treatment significantly lowers BMI in obese children aged 6 to <12, but gastrointestinal side effects prompt the need for additional studies.

13 Sep 2024

Research highlights cardiovascular benefits of semaglutide for overweight adults with impaired kidney function

The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with overweight or obesity who don't have diabetes, whether or not they also have impaired kidney function, according to new research to be presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).

13 Sep 2024

Significant global cardiovascular risk linked to high lipoprotein(a) levels

Review in The Lancet finds that one in five globally are at risk of contracting cardiovascular diseases, because they carry a genetic risk of high levels of a specific lipoprotein, which can be tested for and possibly treated.

12 Sep 2024

New study links lower Nutri-score foods to increased cardiovascular risk

Cardiovascular diseases are the leading cause of mortality in Western Europe, accounting for 1/3 of deaths in 2019.

12 Sep 2024

Swift management of gestational diabetes lowers child obesity rates

Swiftly achieving glycemic control after a diagnosis of gestational diabetes can bring the baby's risk obesity in childhood down to a level similar to that of children whose mothers did not have gestational diabetes, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September), has found.

12 Sep 2024

Pet ownership did not improve mental health symptoms during COVID-19 pandemic

Researchers assess the relationship between pet ownership during the COVID-19 pandemic and mental health outcomes.

12 Sep 2024

In Montana, 911 calls reveal impact of heat waves on rural seniors

Missoula is one of Montana's largest cities but is surrounded by rural mountain communities where cattle ranching is king.

12 Sep 2024

Atrial fibrillation affects more Americans than previously estimated

Atrial fibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought, affecting nearly 5% of the population, or 10.5 million U.S. adults, according to new estimates from UC San Francisco.

11 Sep 2024

Study reveals lower risk of atrial fibrillation after quitting smoking

Quitting cigarettes can significantly lower a person's risk of atrial fibrillation (AFib) compared to those who continue to smoke, according to a study published today in JACC: Clinical Electrophysiology.

11 Sep 2024

Brazilian research uncovers how liver nerves regulate glucose production under stress

A study led by Brazilian researchers has produced a detailed description of the morphology of the nerves in the liver and how they control production of glucose when the organism is under stress.

11 Sep 2024

Throat problems linked to decreased baroreflex sensitivity

Patients with throat problems were less able to regulate their blood pressure in a new study led by the University of Southampton.

11 Sep 2024

World champion marathon runner’s life study highlights benefits and risks of life-long endurance exercise

Decades of intense marathon training have preserved heart function in a 77-year-old, highlighting benefits and risks of extreme endurance exercise.

11 Sep 2024

COVID-19 mRNA vaccine linked to myocardial scarring in adolescents and young adults

The study investigates COVID-19 vaccine-related myocarditis in adolescents, revealing clinical characteristics and risks of myocardial injury in young adults.

11 Sep 2024

Promising new approach to combat HIV

Researchers at Université de Montréal's affiliated hospital research center, the CRCHUM, say the discovery could help lessen and even eliminate viral loads in people undergoing antiretroviral therapy.

11 Sep 2024

Air pollution spikes drive unnecessary antibiotic use, fueling resistance

Short-term exposure to air pollution significantly increases antimicrobial use for acute respiratory symptoms, highlighting a potential contributor to antibiotic resistance.

10 Sep 2024

Diligence associated with better cardiovascular outcomes in type 2 diabetes patients

People with type 2 diabetes, who display lower levels of diligence, may have a significantly higher risk of developing cardiovascular disease with which diabetes is strongly associated, finds research published in the open access journal BMJ Open Diabetes Research & Care.

10 Sep 2024

Previous
1
...
57
58
59
60
61
62
63
...
2908
Next

Heart Disease News and Research

Latest Heart Disease News and Research

Mount Sinai researchers uncover genetic basis of fibromuscular dysplasia

Semaglutide and tirzepatide significantly improve weight loss and glycemic control in type 1 diabetes

Coordinated health teams may help improve outcomes for children with Trisomy 21 and heart conditions

Advanced insulin pump technology improves diabetes management for marathon runners

Obesity medication liraglutide is safe and effective in children aged 6 to <12 years

Research highlights cardiovascular benefits of semaglutide for overweight adults with impaired kidney function

Significant global cardiovascular risk linked to high lipoprotein(a) levels

New study links lower Nutri-score foods to increased cardiovascular risk

Swift management of gestational diabetes lowers child obesity rates

Pet ownership did not improve mental health symptoms during COVID-19 pandemic

In Montana, 911 calls reveal impact of heat waves on rural seniors

Atrial fibrillation affects more Americans than previously estimated

Study reveals lower risk of atrial fibrillation after quitting smoking

Brazilian research uncovers how liver nerves regulate glucose production under stress

Throat problems linked to decreased baroreflex sensitivity

World champion marathon runner’s life study highlights benefits and risks of life-long endurance exercise

COVID-19 mRNA vaccine linked to myocardial scarring in adolescents and young adults

Promising new approach to combat HIV

Air pollution spikes drive unnecessary antibiotic use, fueling resistance

Diligence associated with better cardiovascular outcomes in type 2 diabetes patients

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Heart Disease News and Research

Latest Heart Disease News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in